Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
118 |
|
| Actual shortage: | 19 (16%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 2 (2%) | |
| Resolved: | 97 (82%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 4 (80%) | |
| Discontinued: | 1 (20%) | |
| Reversed: | 0 (0%) | |
Late reports |
28 (23%) |
|
Overdue reports |
5 (22%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2022-03-03 | 2022-09-10 | 155959 |
| CALCITRIOL INJECTION USP | 2MCG | SOLUTION | Resolved | 2017-04-27 | 2021-08-11 | 8288 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2017-06-15 | 2017-08-15 | 12797 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2019-03-15 | 2019-07-02 | 78723 |
| TRANEXAMIC ACID TABLETS | 500MG | TABLET | Resolved | 2019-02-08 | 2019-02-23 | 75140 |
| TRANEXAMIC ACID TABLETS | 500MG | TABLET | Resolved | 2019-06-06 | 2019-06-21 | 85765 |
| TRANEXAMIC ACID TABLETS | 500MG | TABLET | Resolved | 2020-03-31 | 2020-04-07 | 110244 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10G | POWDER FOR SOLUTION | Resolved | 2017-06-16 | 2017-08-17 | 12947 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10G | POWDER FOR SOLUTION | Resolved | 2022-12-13 | 2023-01-06 | 178276 |
| TETRABENAZINE TABLETS | 25MG | TABLET | Resolved | 2018-01-08 | 2018-06-23 | 35110 |
| BACLOFEN INJECTION | 0.5MG | SOLUTION | Resolved | 2017-09-15 | 2017-09-20 | 22147 |
| MERCAPTOPURINE TABLETS USP | 50MG | TABLET | Resolved | 2020-03-31 | 2020-04-07 | 110211 |
| FOMEPIZOLE FOR INJECTION | 1G | SOLUTION | Resolved | 2019-08-16 | 2019-08-24 | 91678 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80085 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162207 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-02-14 | 182605 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80088 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-15 | 162210 |
| CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-05-25 | 8810 |
| CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162221 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Discontinued | 2024-01-15 | 2024-06-01 | 216017 |
| STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2023-11-06 | 2023-11-06 | 209235 |
| MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | To be discontinued | 2024-01-22 | 2024-02-06 | 216963 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223140 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223145 |
Showing 1 to 5 of 5